Lung Cancer Considered in Spanish: Neoadjuvant Therapies In NSCLC
Estela Rodriguez shared a post on X:
“In this episode of IASLC’s (The International Association for the Study of Lung Cancer) Lung Cancer Considered, Narjust Florez moderates a discussion in Spanish about perioperative chemotherapy and immunotherapy and how recent studies may affect clinical decisions for patients with Lung Cancer in LATAM. With expert guests Clarissa Baldotto and Paula Ugalde.
Listen to the podcast here.”
Source: Estela Rodriguez/X
Estela Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023